Wells Fargo & Company Silo Pharma, Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Silo Pharma, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 17 shares of SILO stock, worth $16. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17
Previous 20
15.0%
Holding current value
$16
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SILO
# of Institutions
12Shares Held
113KCall Options Held
0Put Options Held
0-
Financial Advocates Investment Management Olympia, WA62.8KShares$59,6660.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.3KShares$15,5170.0% of portfolio
-
Geode Capital Management, LLC Boston, MA16.2KShares$15,3700.0% of portfolio
-
State Street Corp Boston, MA12.5KShares$11,8750.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY4.43KShares$4,2100.0% of portfolio
About Silo Pharma, Inc.
- Ticker SILO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,137,910
- Market Cap $2.98M
- Description
- Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University ...